Desflurane consumption with the Zeus during automated closed circuit versus low flow anesthesia. 2009

S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
Department of Anesthesiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

BACKGROUND During automated closed-circuit anesthesia (CCA), the Zeus (Dräger, Lübeck, Germany) uses a high initial fresh gas flow (FGF) to rapidly attain the desired agent and carrier gas concentrations, resulting in a desflurane consumption well above patient uptake. Because both FGF and carrier gas composition can affect consumption, we determined the Zeus' agent consumption with automated CCA and with automated low flow anesthesia (LFA) (= maintenance FGF of 0.7 L min(-1)) with 3 different carrier gases. METHODS After IRB approval, 65 ASA PS I or II patients undergoing general surgery received desflurane in either O2, O2/air, or O2/N2O, with the Zeus to maintain the end-expired concentration (FA) at 6, 6, and 4% and the F1O2 at 1.0, 0.6, and 0.4, respectively. In addition, patients were assigned to either automated CCA (O2 n = 11; O2/air n = 11; O2/N2O n = 11) or automated LFA (selected FGF 0.7 L min(-1)) (O2 n = 12; O2/air n = 11; O2/N2O n = 9). Demographics and desflurane consumption at 2, 4, 6, 8, 10, 20, 30, 40 and 50 min were compared. RESULTS With the same carrier gas, desflurane consumption was lower with the CCA mode than with LFA mode after 4 min in the O2 groups, 6 min in the O2/air groups, and 30 min in the O2/N2O groups. Within each mode, desflurane consumption in the O2 and O2/air groups was identical at all times. Despite the use of a lower FA in the N2O groups, initial desflurane consumption was higher than in the O2 and O2/air groups, but it was lower later (> or = 15 min) only with LFA. CONCLUSIONS After 50 min, desflurane consumption with automated CCA is lower than with automated LFA. However, initial agent consumption is complex, and N2O in particular may increase initial desflurane consumption (though ultimately resulting in lower desflurane usage because of its MAC sparing effect) because initial FGF is increased to rapidly reach the target concentrations. Differences in desflurane consumption only become apparent after FGF has stabilized to the target FGF.

UI MeSH Term Description Entries
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077335 Desflurane A fluorinated ether that is used as a volatile anesthetic for maintenance of general anesthesia. 1,2,2,2-Tetrafluoroethyl difluoromethyl ether,I 653,I-653,I653,Suprane
D000764 Anesthesia, Closed-Circuit Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible. Anesthesia, Rebreathing,Closed-Circuit Anesthesia,Anesthesia, Closed Circuit,Anesthesias, Closed-Circuit,Anesthesias, Rebreathing,Closed Circuit Anesthesia,Closed-Circuit Anesthesias,Rebreathing Anesthesia,Rebreathing Anesthesias
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D018685 Anesthetics, Inhalation Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) Inhalation Anesthetic,Inhalation Anesthetics,Anesthetic Gases,Anesthetic, Inhalation,Gases, Anesthetic

Related Publications

S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
July 2014, BMC research notes,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
October 1994, Masui. The Japanese journal of anesthesiology,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
January 1996, Acta anaesthesiologica Belgica,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
April 1997, Der Anaesthesist,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
May 1997, Revista espanola de anestesiologia y reanimacion,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
January 1990, Acta anaesthesiologica Belgica,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
January 1990, Acta anaesthesiologica Belgica,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
January 1984, Contemporary anesthesia practice,
S De Cooman, and A Lecain, and M Sosnowski, and A M De Wolf, and J F A Hendrickx
February 1995, Masui. The Japanese journal of anesthesiology,
Copied contents to your clipboard!